Bridge Of Writing (Domination #1) by DeYtH Banger (finding audrey TXT) 📖

problem faced by all of these systems is how to optimally organize the supply or reserve workforce such as to minimize the costs of maintaining these reserves.”

 

“My speculation is this: Since young workers start out as the most vulnerable members of the colony, it makes sense for them to lay low and be inactive,” Charbonneau says. “And because their ovaries are the most active, they produce eggs, and while they’re doing that, they might as well store food. When the colony loses workers, it makes sense to replace them with those ants that are not already busy pursuing other tasks.”

Here's What Psychoanalysis Really Is, And What Science Says About Whether It Works

 by Christine Bett

 

 

Psychoanalysis or psychoanalytic psychotherapy is a way of treating longstanding psychological problems that is based on the belief behaviours have underlying drivers which may be unrecognised and unconscious.

With this understanding it's possible to think about the meaning and reasons behind that behaviour and enable the possibility of change.

Although Freud's psychology of the mind was premised on the existence of an unconscious, he was not the originator of the term.

Seventeenth-century Western philosophers John Locke and René Descartes and, later, Gottfried Wilhelm Liebniz grappled with the idea of an unconscious, speculating the existence of something within the mind, beyond awareness, that also influenced behaviour.

 

Reasons for seeking psychoanalytic treatment

 

People seek psychoanalytic assistance for many reasons – patterns of failed or destructive relationships, work stress, depression or anxiety, personality disorders or issues around self-identity and sexuality. Some seek therapy after a significant loss, whether through death or divorce, or as a result of a traumatic event or abuse in childhood or adolescence.

People may see a psychoanalytic psychotherapist one or more times per week over months or years. A psychoanalyst may see someone four or five times a week.

Consistent, regular appointments of 45 or 50 minutes enable over time the development of insight about patterns of thinking and behaviour and the way these affect the person in terms of their emotional state as well as relationships with partners, families, friends, work and the community.

In Australia, people who consult a psychoanalyst or psychoanalytic psychotherapist who is medically trained, either as a psychiatrist or other medical practitioner, are able to claim for sessions under Medicare on an ongoing basis.

People who are in therapy or analysis with non-medical practitioners may be able to claim up to ten consultations per calendar year under Medicare, depending on the therapist's professional qualifications.

Training in psychoanalysis and psychoanalytic psychotherapy generally takes place over a period of at least five years. It is open to professionals from various disciplines such as psychiatry, general practice, psychology, social work and nursing.

The training includes a developmental perspective, which considers the impact experiences in infancy and childhood may have on the individual in later life.

It involves theory, supervised clinical work and observation of an infant from birth for one year with accompanying seminars. All trainees undertake personal analysis or psychoanalytic psychotherapy for the duration of their training.

 

The treatment process

 

In a session, patients try to say all that comes to mind, allowing thoughts, feelings, memories and dreams to emerge. To enable this, some lie on a couch with the therapist sitting behind them; others sit face to face with the therapist.

In this confidential setting, and as trust develops, clues to the patient's unconscious and internal world begin to form, and relationship patterns and avoidances become visible.

The analyst listens carefully to the patient's reflections, dreams, memories and thoughts and tries to explore what they mean.

It is hoped the patient will develop insight into destructive life patterns and the way these were formed, and understand them as a response to their life events and relationships.

 

Is it effective?

 

There is considerable debate about the effectiveness of psychoanalytic treatment. One problem is the reluctance of the psychoanalytic profession to recognise the value of formal research and evidence in the development of this work. Another is the difficulty of studying the treatment due to its long-term nature.

A 2012 article stated:

… psychoanalysis is no longer recommended for treating mental illness due to a lack of evidence. A recently published review was unable to find a single randomised controlled trial evaluating classic psychoanalysis and the evidence for long-term, 'modern' psychoanalysis was conflicting at best.

However, since then studies with more positive results have been conducted and published.

In 2015, the Tavistock Adult Depression Study was published examining the effectiveness of psychoanalytic psychotherapy. The study used the random control trial model to examine the treatment of a cohort of patients diagnosed with long-standing major depression and who had failed at least two different treatments.

One group underwent psychoanalytic psychotherapy for two years; the other control group was treated with cognitive behavioural therapy – where patients learn new ways to think and behave.

While the results were not significantly different between the two groups at the end of treatment, significant differences emerged during follow-up at 24, 30 and 42 months.

Both observer-based and self-reported depression scores showed steeper declines in the psychoanalytic psychotherapy group, alongside greater improvements in how they coped socially, than in the cognitive behavioural therapy group. This suggests long-term psychoanalytic psychotherapy is useful in improving the long-term outcome of treatment-resistant depression.

A second study led by the same author, published in 2016, looked at parent-infant psychoanalytic psychotherapy, which aims to improve the interaction between parent and child. Participants were allocated randomly to parent-infant psychotherapy and to supportive primary care.

There was no significant difference in outcome on measures of infant development, parent–infant interaction or the ability of the parent to consider the baby's mental state as well as their own.

However, those who had received parent-infant psychotherapy showed improvements on several measures of maternal mental health, including parenting stress, and parental representations of the baby and their relationship. This suggested psychoanalytic psychotherapy has potential for improving the parent-infant relationship.

Critics of psychoanalysis have argued against the length of treatment and that it is costly and thus the province of the "worried well" living in leafy middle-class suburbs. A patient seeking psychotherapy may not want nor require long-term treatment, seeking only to sort out a few matters. It may be that cognitive behavioural therapy or another therapy is the more appropriate option for a particular patient.

It is often not possible to sustain long-term psychoanalytic psychotherapy within the funding constraints of the public mental health and welfare system. More solution-focused and single-session therapies can be used with individuals and families in distress.

The ConversationPsychoanalytic psychotherapy is not readily available in regional, rural and remote areas. While "distance therapy" is available via technologies such as Skype, Facetime, Zoom and telephone, this needs to be evaluated to see if it has the same effect as face-to-face therapy.

This Is How Weed Actually Affects Your Sleep

by Deidre Conroy

 

 

If you speak to someone who has suffered from insomnia at all as an adult, chances are good that person has either tried using marijuana, or cannabis, for sleep or has thought about it.

 

This is reflected in the many variations of cannabinoid or cannabis-based medicines available to improve sleep – like Nabilone, Dronabinol and Marinol. It's also a common reason why many cannabis users seek medical marijuana cards.

I am a sleep psychologist who has treated hundreds of patients with insomnia, and it seems to me the success of cannabis as a sleep aid is highly individual. What makes cannabis effective for one person's sleep and not another's?

While there are still many questions to be answered, existing research suggests that the effects of cannabis on sleep may depend on many factors, including individual differences, cannabis concentrations and frequency of use.

Cannabis and sleep

Access to cannabis is increasing. As of last November, 28 US states and the District of Columbia had legalised cannabis for medicinal purposes.

 

Research on the effects of cannabis on sleep in humans has largely been compiled of somewhat inconsistent studies conducted in the 1970s. Researchers seeking to learn how cannabis affects the sleeping brain have studied volunteers in the sleep laboratory and measured sleep stages and sleep continuity. Some studies showed that users' ability to fall and stay asleep improved. A small number of subjects also had a slight increase in slow wave sleep, the deepest stage of sleep.

However, once nightly cannabis use stops, sleep clearly worsens across the withdrawal period.

Over the past decade, research has focused more on the use of cannabis for medical purposes. Individuals with insomnia tend to use medical cannabis for sleep at a high rate. Up to 65 percent of former cannabis users identified poor sleep as a reason for relapsing. Use for sleep is particularly common in individuals with PTSD and pain.

 

This research suggests that, while motivation to use cannabis for sleep is high, and might initially be beneficial to sleep, these improvements might wane with chronic use over time.

Does frequency matter?

 

We were interested in how sleep quality differs between daily cannabis users, occasional users who smoked at least once in the last month and people who don't smoke at all.

We asked 98 mostly young and healthy male volunteers to answer surveys, keep daily sleep diaries and wear accelerometers for one week. Accelerometers, or actigraphs, measure activity patterns across multiple days. Throughout the study, subjects used cannabis as they typically would.

Our results show that the frequency of use seems to be an important factor as it relates to the effects on sleep. Thirty-nine percent of daily users complained of clinically significant insomnia. Meanwhile, only 10 percent of occasional users had insomnia complaints. There were no differences in sleep complaints between nonusers and nondaily users.

Interestingly, when controlling for the presence of anxiety and depression, the differences disappeared. This suggests that cannabis's effect on sleep may differ depending on whether you have depression or anxiety. In order words, if you have depression, cannabis may help you sleep – but if you don't, cannabis may hurt.

Future directions

Cannabis is still a schedule I substance, meaning that the government does not consider cannabis to be medically therapeutic due to lack of research to support its benefits. This creates a barrier to research, as only one university in the country, University of Mississippi, is permitted by the National Institute of Drug Abuse to grow marijuana for research.

New areas for exploration in the field of cannabis research might examine how various cannabis subspecies influence sleep and how this may differ between individuals.

 

 

One research group has been exploring cannabis types or cannabinoid concentrations that are preferable depending on one's sleep disturbance. For example, one strain might relieve insomnia, while another can affect nightmares.

Other studies suggest that medical cannabis users with insomnia tend to prefer higher concentrations of cannabidiol, a nonintoxicating ingredient in cannabis.

This raises an